Dissection of Differentially Expressed Genes and Pathways in Patients With OSAS Before and After CPAP Treatment
1 other identifier
observational
50
1 country
1
Brief Summary
Specific Aim
- 1.To verify the differentially expressed genes and pathways between normal and OSA patients, and OSA patients before and after CPAP treatment.
- 2.To correlate the confirmed genes with the clinical presentations and CPAP effects in another 50 OSAS subjects to validate the altered gene expressions and pathways involved.
- 3.To establish a cell model to investigate the differentially expressed genes and the putative biological pathways involved in OSA syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 8, 2007
CompletedFirst Posted
Study publicly available on registry
July 10, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedDecember 1, 2010
November 1, 2010
9 months
July 8, 2007
November 30, 2010
Conditions
Keywords
Interventions
CPAP treatment for 4 weeks
Eligibility Criteria
From patients who were referred to sleep lab for suspect sleep apnea, we selected 50 male patients with age\> 18 y/o. with severe OSAS, which were confirmed with by overnight PSG. All were free from neurologic events, chronic pulmonary disease, active infection and substance abuse. Female patients and patients under 18 y/o were excluded. All 50 subjects were treated with 4-week CPAP. All study subjects were admitted, on the day of baseline measurement and four weeks after CPAP use, for clinical evaluation, blood sampling and PSG. And all anti-hypertensive therapy was remained unchanged during the 4-week follow-up period. Changes of parameters, before and after CPAP treatment, were compared between two groups.
You may qualify if:
- Severe obstructive sleep apnea (AHI\>=30/hr) age, sex, BMI match control subject
You may not qualify if:
- Refused to participate in this study
- Had severe obstructive pulmonary disease or active neurological events
- Enrolled in other studies at the same time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peilin Lee, M.D.
National Taiwan University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 8, 2007
First Posted
July 10, 2007
Study Start
June 1, 2007
Primary Completion
March 1, 2008
Study Completion
July 1, 2008
Last Updated
December 1, 2010
Record last verified: 2010-11